Logo

Kailos PGxComplete

Oct 14, 2015

Kailos has launched PGxComplete, a comprehensive, full panel, gene-based test that the company is offering for $99 through November 30. The panel tests 20 different classes of medications to reveal how one's body responds to more than 50 types of medications, including antidepressants, opioids, HIV/AIDS treatment, and cancer therapy. The panel uses advanced technology that harnesses DNA sequencing and enables a more holistic view of a person's gene-based medical information, said Kailos in a statement. The company launched its first pharmacogenetics test (the Kailos test, formerly called Praxis) this past June. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.